NCT00304603View on ClinicalTrials.gov

Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

1,145

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
ObesityDiabetes Mellitus Type 2
Interventions
OTHER

No intervention

No treatment was given to the patients as this is an observational study.

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00304603 - Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter